FDA Clears Shoulder Innovations’ Augmented Glenoid Implants

The FDA handed Shoulder Innovations 510(k) clearance for its InSet Plus augmented glenoids for the InSet Total Shoulder System.

The implant system is used to treat significant disability in degenerative, rheumatoid and traumatic disease of the shoulder joint and avascular necrosis of the humeral head, and features implanted glenoid technology.

The new InSet Plus glenoids have an angled articular surface and come in two versions with multiple diameters.